Ichthyosis – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2023 To 2033
Ichthyosis is a collection of skin diseases that causes dry, itchy skin that appears red, scaly, and rough. There is a spectrum of symptoms from minor to severe. Ichthyosis symptoms can vary in severity from minor to severe. The inherited forms of ichthyosis are all caused by mutations in the genes. Numerous gene alterations have been found; the inheritance pattern varies according to the kind of ichthyosis. The ichthyoses represent a diverse array of skin cornification disorders, encompassing both inherited and acquired forms. They result from abnormalities in keratinocyte differentiation and the epidermal barrier formation. Consequently, there is an increase in transepidermal water loss and inflammation due to compromised skin barrier function. Clinically, disordered cornification manifests as skin scaling, varying degrees of thickening, desquamation (peeling), and erythema (redness). Regardless of the specific type of ichthyosis, patients often experience itching, recurrent infections, impaired sweating (hypohidrosis) leading to heat intolerance, as well as a range of ocular, hearing, and nutritional complications necessitating periodic monitoring. These characteristic clinical features are believed to represent a homeostatic response aimed at repairing the skin barrier. However, the heterogeneous clinical presentation and imperfect correlation between phenotype and genotype pose challenges to accurate diagnosis. For now, there is no treatment for ichthyosis. Treatment objectives include reducing skin redness, scaling thickness, and irritation. One of the treatments is to hydrate the skin and apply ointments or lotions to help hydrate the skin and reduce scaling and dryness.
Thelansis’s “Ichthyosis Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2023 To 2033" covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential Ichthyosis treatment modalities options for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and China).
KOLs insights of Ichthyosis across 8 MM market from the centre of Excellence/ Public/ Private hospitals participated in the study. Insights around current treatment landscape, epidemiology, clinical characteristics, future treatment paradigm, and Unmet needs.
Ichthyosis Market Forecast Patient Based Forecast Model (MS. Excel Based Automated Dashboard), which Data Inputs with sourcing, Market Event, and Product Event, Country specific Forecast Model, Market uptake and patient share uptake, Attribute Analysis, Analog Analysis, Disease burden, and pricing scenario, Summary, and Insights.
Thelansis Competitive Intelligence (CI) practice has been established based on a deep understanding of the pharma/biotech business environment to provide an optimized support system to all levels of the decision-making process. It enables business leaders in forward-thinking and proactive decision-making. Thelansis supports scientific and commercial teams in seamless CI support by creating an AI/ ML-based technology-driven platform that manages the data flow from primary and secondary sources.
Comments
Post a Comment